AES Medical Brief History 

 
Formed in 1999 the AES Medical remit was to transfer the success AES Group had already had with its software engineering and artificial intelligence skills into the healthcare sector.
 
This initially took the form of a project with Nottingham University Hospitals NHS Trust to develop a pathology IT system to assist in the diagnosis of Suspected Chronic Inflammatory Bowel Disease (CIBD). This system developed with the pathology department at the Queens Medical Centre enhanced the guidelines published by the British Society of Gastroenterology for the initial diagnosis of suspected Chronic Inflammatory Bowel Disease.
 
Around 2001 AES Medical expanded its product portfolio. At this time the first Royal College of Pathologists datasets had begun to appear and AES Medical again teamed up with the NHS (this time the PathLinks pathology network) to develop a new system to enable collection and audit of the datasets as a by-product of the reporting process. This led to the first iteration of the pathology reporting system PathoSys® which was linked to the iSoft CILMS system in use at PathLinks. 
 
In 2004 based on the success of the initial PathoSys® product AES Medical began development of the second iteration of the PathoSys® system. Key improvements in this product included built in support for Pathology Networks, a more modular architecture to encompass more datasets and more modern technologies.
 
2005/6 saw the initial roll-out of the improved PathoSys® solution. AES Medical then began work during 2007 with cancer registries to start looking at making use of the electronic structured data being collected by PathoSys®. The NEWPath network then went on to procure PathoSys® for the Tyne region of North East of England in 2008. The first site of which went live the following year. 
 
2010 was a busy year with record sales of PathoSys® and the development of the interface to the CliniSys Winpath Laboratory system. The remote IT infrastructure for the expanded NEWPath project (now NEPath covering the whole North of England Cancer Network) was finalised and connectivity roll-out commenced. 
 
This led in 2011 to the first remote NEPath network sites going live enabling for the first time Network wide real time audit of structured histopathology data. Also this year following and a competitive OJEC tender AES Medical was awarded by University Hospitals of Leicester NHS Trust a contract to develop HaemoSys®, a haematology reporting system which builds on the principles of PathoSys® to deliver network wide integrated reporting of Haematological Malignancies. HaemoSys® went live at University Hospitals of Leicester NHS Trust at the end of 2011.